Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Fish and Richardson
McKesson
Julphar
Moodys
Johnson and Johnson
Citi
Farmers Insurance
Teva
Federal Trade Commission

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016273

« Back to Dashboard

NDA 016273 describes LASIX, which is a drug marketed by Sanofi Aventis Us and Us Pharm Holdings and is included in three NDAs. It is available from two suppliers. Additional details are available on the LASIX profile page.

The generic ingredient in LASIX is furosemide. There are twenty-one drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the furosemide profile page.
Summary for 016273
Tradename:LASIX
Applicant:Us Pharm Holdings
Ingredient:furosemide
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 016273
Medical Subject Heading (MeSH) Categories for 016273
Suppliers and Packaging for NDA: 016273
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LASIX furosemide TABLET;ORAL 016273 NDA Sanofi-Aventis U.S. LLC 0039-0060 0039-0060-70 1000 TABLET in 1 BOTTLE (0039-0060-70)
LASIX furosemide TABLET;ORAL 016273 NDA Sanofi-Aventis U.S. LLC 0039-0060 0039-0060-50 500 TABLET in 1 BOTTLE (0039-0060-50)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength40MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength80MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired US Patents for NDA 016273

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharm Holdings LASIX furosemide TABLET;ORAL 016273-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Us Pharm Holdings LASIX furosemide TABLET;ORAL 016273-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Us Pharm Holdings LASIX furosemide TABLET;ORAL 016273-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Army
Dow
Express Scripts
Harvard Business School
Fuji
QuintilesIMS
Daiichi Sankyo
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot